Cargando…

Severe spruelike enteropathy and collagenous colitis caused by olmesartan

BACKGROUND: Olmesartan, which is an angiotensin II receptor blocker, reportedly causes spruelike enteropathy, with intestinal villous atrophy as its typical histopathological finding. Interestingly, collagenous and/or lymphocytic gastritis and colitis occur in some patients. We report the case of a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kaneko, Shiho, Matsuda, Kana, Mizuta, Yasuko, Shiratori, Shoya, Kishi, Kazuma, Nakamura, Akihisa, Yagisawa, Masataka, Ehira, Nobuyuki, Uebayashi, Minoru, Kobayashi, Hiroya
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8461977/ https://www.ncbi.nlm.nih.gov/pubmed/34556042 http://dx.doi.org/10.1186/s12876-021-01926-y

Ejemplares similares

Spruelike Enteropathy Associated with Olmesartan: An Unusual Case of Severe Diarrhea
por: Dreifuss, Stephanie E., et al.
Publicado: (2013)

Olmesartan-Induced Spruelike Enteropathy: An Emerging Cause of Small Bowel Injury
por: Malik, Adnan, et al.
Publicado: (2020)

Enteropathy Associated with Olmesartan
por: Silva, Bruno Moreira da, et al.
Publicado: (2015)

Olmesartan-Induced Sprue Like Enteropathy
por: Carneiro, Liliana, et al.
Publicado: (2016)

Rare Case of Olmesartan Induced Enteropathy
por: Handa, Richa, et al.
Publicado: (2017)

Olmesartan‐induced enteropathy associated with cutaneous lesions
por: Hammoudi, Nassim, et al.
Publicado: (2016)

A Case Report of Olmesartan-Induced Enteropathy
por: Daines, Benjamin S, et al.
Publicado: (2021)

Olmesartan-Induced Enteropathy: A Case Report
por: Jadvani, Dharmikkumar, et al.
Publicado: (2023)

Sprue-Like Enteropathy Associated with Olmesartan: An Unrecognized Emerging Drug-Induced Enteropathy?
por: Lourenço, Luís Carvalho, et al.
Publicado: (2016)

Sprue-Like Enteropathy Associated With Olmesartan: A New Kid on the Enteropathy Block
por: Hujoel, Isabel A., et al.
Publicado: (2016)

Olmesartan Associated Sprue-Like Enteropathy and Colon Perforation
por: Abdelghany, Mahmoud, et al.
Publicado: (2014)

Gastrointestinal Disorder Associated with Olmesartan Mimics Autoimmune Enteropathy
por: Scialom, Sophie, et al.
Publicado: (2015)

Small bowel enteropathy associated with olmesartan medoxomil treatment
por: Galanopoulos, Michail, et al.
Publicado: (2017)

Olmesartan-induced Enteropathy Manifesting as Wernicke-Korsakoff Syndrome
por: Uehara, Takanori, et al.
Publicado: (2016)

Olmesartan-Induced Enteropathy: An Unusual Cause of Villous Atrophy
por: Eusébio, Marta, et al.
Publicado: (2015)

Olmesartan-Associated Enteropathy: An Unexpected Cause of Chronic Diarrhoea
por: Teixeira, Mónica, et al.
Publicado: (2019)

Olmesartan-Induced Enteropathy: A Case of Recurrent Diarrhoea
por: Fernandes Matos, Ana Rita, et al.
Publicado: (2020)

Olmesartan-medoxomil: Sprue-like enteropathy: case report
Publicado: (2021)

Olmesartan-associated Enteropathy Mimics Endoscopic Findings of Celiac Disease
por: Sasaki, Sho, et al.
Publicado: (2020)

Olmesartan-associated enteropathy: heterogeneity of involvement along gastrointestinal tract
por: Dias, Emanuel, et al.
Publicado: (2020)

Case of olmesartan-associated enteropathy and transient positive antitissue transglutaminase serology
por: Ghaith, Jenan, et al.
Publicado: (2018)

Olmesartan-Induced Enteropathy: A Report of an Unusual Cause of Chronic Diarrhea
por: Sotiropoulos, Christos, et al.
Publicado: (2021)

Olmesartan Associated Enteropathy: A Rare Underdiagnosed Cause of Diarrhea and Weight Loss
por: Gonakoti, Sripriya, et al.
Publicado: (2019)

Olmesartan is not associated with the risk of enteropathy: a Korean nationwide observational cohort study
por: You, Seng Chan, et al.
Publicado: (2019)

Olmesartan-induced Enteropathy: A Rare Side Effect of a Common Medication
por: Sher, Mustafa, et al.
Publicado: (2019)

Sprue-Like Enteropathy and Liver Injury: A Rare Emerging Association with Olmesartan
por: Odak, Mihir, et al.
Publicado: (2021)

A Rare Case of Olmesartan-Associated Enteropathy Successfully Managed With Steroid Taper
por: Xue, Angela, et al.
Publicado: (2023)

A235 “WHAT’S SPRUE WITH YOU?”: OLMESARTAN-INDUCED ENTEROPATHY AS AN UNCOMMON MIMICKER OF CELIAC DISEASE
por: Milne, F, et al.
Publicado: (2023)

Severe Sprue-Like Enteropathy and Colitis due to Olmesartan: Lessons Learned From a Rare Entity
por: Bashari, Daniel R.
Publicado: (2020)

A case report of olmesartan‐associated sprue‐like enteropathy: Diagnosis and healing confirmed by capsule endoscopy
por: Yamaguchi, Yoshiharu, et al.
Publicado: (2022)

Telmisartan-induced sprue-like enteropathy: a case report and a review of patients using non-olmesartan angiotensin receptor blockers
por: Mandavdhare, Harshal Surendra, et al.
Publicado: (2017)

Olmesartan/amlodipine vs olmesartan/hydrochlorothiazide in hypertensive patients with metabolic syndrome: the OLAS study
por: Martinez-Martin, F J, et al.
Publicado: (2011)

Acute onset collagenous colitis associated with protein‐losing enteropathy
por: Nakaya, Yuichiro, et al.
Publicado: (2017)

Olmesartan: Induced maculopapular rash
por: Bhushan, Aruna, et al.
Publicado: (2013)

Enteropatía secundaria a olmesartán
por: Curieses Luengo, María, et al.
Publicado: (2017)

Difference in the effects of switching from Candesartan to Olmesartan or Telmisartan to Olmesartan in hypertensive patients with type 2 diabetes: the COTO study
por: Daikuhara, Hiroyuki, et al.
Publicado: (2014)

Olmesartan medoxomil combined with hydrochlorothiazide for the treatment of hypertension
por: Greathouse, Mark
Publicado: (2006)

Spectrophotometric Estimation of Olmesartan Medoxomil and Hydrochlorothiazide in Tablet
por: Rote, A. R., et al.
Publicado: (2010)

Olmesartan medoxomil for the treatment of hypertension in children and adolescents
por: Tocci, Giuliano, et al.
Publicado: (2011)

Formulation and Evaluation of Liquisolid Compacts for Olmesartan Medoxomil
por: Prajapati, Shailesh T., et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_8ra796jo3ir8altu2vsha89ldq